Incyte (INCY)
(Real Time Quote from BATS)
$59.18 USD
+0.02 (0.03%)
Updated Jun 10, 2024 02:50 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Incyte Corporation [INCY]
Reports for Purchase
Showing records 201 - 220 ( 248 total )
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Key Takeaways From Meeting With Management
Provider: Nomura
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Previewing 4Q13 and 2014 Guidance
Provider: Nomura
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Initiating with Buy Rating and $68 TP
Provider: Nomura
Company: Incyte Corporation
Industry: Medical - Biomedical and Genetics
Initiating on US Biotechnology Sector
Provider: Nomura